KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
2024 · Kidney International · 6,568 citations
https://doi.org/10.1016/j.kint.2023.10.018
W
William G. Herrington
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
273
Papers
25.8K
Citations
59
h-index
130
i10-index
William G. Herrington is an academic researcher from University of Oxford. The author has contributed to research in topics: Chronic Kidney Disease and Diabetes & Diabetes Treatment and Management & Dialysis and Renal Disease Management. The author has an h-index of 59, co-authored 233 publications.
ORCID: 0000-0003-1172-8243Papers by this author
worksEmpagliflozin in Patients with Chronic Kidney Disease
2022 · New England Journal of Medicine · 2,205 citations
https://doi.org/10.1056/nejmoa2204233
Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease
2016 · Circulation Research · 1,427 citations
https://doi.org/10.1161/circresaha.115.307611
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
2023 · European Heart Journal · 1,301 citations
https://doi.org/10.1093/eurheartj/ehad192
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
2022 · The Lancet · 918 citations
https://doi.org/10.1016/s0140-6736(22)02074-8
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
2022 · The Lancet · 918 citations
https://doi.org/10.1016/s0140-6736(22)02074-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat